 Insulet Corporation NASDAQ: PODD presented data from the pivotal trial extension phase of the Omnipod 5 Automated Insulin Delivery System. Omnipod 5 is a tubeless, wearable system that continuously adapts insulin delivery based on glucose levels and trends. 